The Value of miR-296 and miR-517c in Evaluating the Prognosis of Patients with Glioma after Radiotherapy and Chemotherapy

Table 2

Expression comparison of miR-517c in gliomas with different pathological features.

Clinicopathological features	n	miR-517c expression quantity	t
Gender
Male	388	2.20 ± 0.43	0.635	0.526
Female	344	2.18 ± 0.42
Age (years)
<50	386	2.37 ± 0.35	2.135	0.033
≥50	346	2.31 ± 0.41
Degree of differentiation
Low	331	2.83 ± 0.30	2.528	0.012
High	401	2.69 ± 0.97
Pathological grading
I–II	376	1.69 ± 0.40	28.054	<0.001
III–IV	356	2.53 ± 0.41
Infiltration depth
≤1/2	421	2.39 ± 0.11	1.150	0.251
>1/2	311	2.42 ± 0.52